TRX585
TRX585 is a humanised anti-immunoglobulin-like transcript 5 (ILT5) monoclonal antibody. TRX585 has a potent immunoregulatory activity. TRX585 significantly activates human T cells and upregulates NKG2D and Fas ligand, followed by enhancing antitumor activity with potent cytotoxicity. TRX585 can be used for viral infections and malignancies research[1].
Product Specifications
UNSPSC
12352203
Target
C-type Lectin-like Receptors (CTLRs)
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Inflammation/Immunology
References & Citations
[1]Apostolou I, et al. Immunoregulatory properties of TRX585, a novel monoclonal antibody specific for immunoglobulin-like transcript 5[J]. Journal of Clinical Oncology, 2010, 28 (15_suppl) : e13107-e13107.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15185927 1 Vial
Lentiviral mouse Fcrla shRNA (UAS) - Lentiviral mouse Fcrla shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details 
MBS6333282-01 0.1 mL
PHF13, CT (PHF13, PHD finger protein 13, Survival time-associated PHD finger protein in ovarian cancer 1) (MaxLight 405)
Sign In for Pricing
View Details MBS6333282-02 5x 0.1 mL
PHF13, CT (PHF13, PHD finger protein 13, Survival time-associated PHD finger protein in ovarian cancer 1) (MaxLight 405)
Sign In for Pricing
View Details A137568 100 µL
Cevostamab without anti-CD3 portion Biosimilar (Monoclonal, IgG1, kappa)
Sign In for Pricing
View Details ![Culture Medium for Human Cervical Cancer Cells [AV3]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
AFG-ELL-1245-01 125 mL
Culture Medium for Human Cervical Cancer Cells [AV3]
Sign In for Pricing
View Details